Document Report Card

Basic Information

ID: ALA5113443

Journal: Bioorg Med Chem Lett

Title: Design, synthesis and properties of peptide inhibitors based on BRCA1856-871.

Authors: Sun G, Zhao Y, Yuan L, Lu K.

Abstract: Overexpression of RAD51 protein was found to increase drug resistance in breast cancer cells. Breast cancer susceptibility gene 1 (BRCA1) protein can specifically bind to RAD51 protein and regulate the expression level of RAD51 protein. Based on previous studies, eight modified peptides were obtained by modifying the N-terminus of the key peptide segment 856-871 of BRCA1 with nicotinic acid (NA) and its derivatives. The interaction of BRCA1856-871 and modified peptides with the RAD51158-180 target peptide was investigated by fluorescence and circular dichroism spectroscopies. The results showed that the binding ability of 2-TFM-NA-PP to RAD51158-180 was significantly enhanced. BRCA1856-871 and modified peptides were studied by in vitro cell experiments. The results showed that the antitumor activity of 5-TFM-NA-PP was significantly enhanced compared with BRCA1856-871.

CiteXplore: 35716865

DOI: 10.1016/j.bmcl.2022.128859